Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
Quick Stats
Jan 30, 202650.0
AI Score
HOLD0.09
Volume Ratio
Mar 13, 2026
Next Earnings
18
+ve Days (30d)
12
-ve Days (30d)
OGEN Stock Summary
Last updated Jan 30, 2026
OGEN is currently trading at $0.8408, positioned below its 200-day moving average of $2.01, suggesting bearish momentum. The stock has a 52-week range of $0.11 to $18.897.
Technical Analysis: The 50-day moving average stands at $0.88, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.981, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.005, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates OGEN at 50.0/100 with a HOLD recommendation.
OGEN (Oragenics Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 44.981 |
| CMF (20) | 0.005 |
| ROC (10) | -10.286 |
| ADX (14) | 14.634 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.016 |
| AROONOSC (14) | -28.571 |
| WILLAMS %R (14) | -73.39 |
| MFI (14) | 2.916 |
OGEN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
OGEN Price vs Max Options Open Interest
OGEN Max Change In Options Open Interest
OGEN Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OGEN Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OGEN Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OGEN Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Oragenics Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
OGEN Moving Averages Analysis
OGEN (Oragenics Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 0.88 |
| 20 | 0.88 |
| 30 | 0.86 |
| 50 | 0.88 |
| 100 | 1.07 |
| 200 | 2.01 |
OGEN Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | 0.0173 |
| Market Cap ($) | 3.5 million |
| Earnings/Share ($) | 48.21 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.76 |
| EPS Estimate Next Year ($) | -0.69 |
| WallStreet Target Price ($) | 2 |
| Most Recent Quarter |